1. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA. 2012;307:491–497. [PubMed] [Google Scholar]
2. Haslam DW, James WP. Obesity. Lancet. 2005;366(9492):1197–1209. [PubMed] [Google Scholar]
3. NIH Technology Assessment Conference Panel. Methods for voluntary weight loss and control. Ann Intern Med. 1992;116:942–949. [PubMed] [Google Scholar]
4. Consensus Development Conference Panel. NIH conference. Gastrointestinal surgery for severe obesity. Ann Intern Med. 1991;115:956–961. [PubMed] [Google Scholar]
5. Foreman C. In: Letter approving LAP-BAND™ Adjustable Gastric Banding System. Services DoHaH, editor. Silver Spring, MD: Center for Devices and Radiological Health of the Food and Drug Administration; 2011. [Google Scholar]
6. Pories WJ. Bariatric surgery: risks and rewards. J Clin Endocrinol Metab. 2008;93(11) Suppl 1:S89–S96. [PMC free article] [PubMed] [Google Scholar]
7. Stimac D, Majanovic SK. Endoscopic approaches to obesity. Dig Dis. 2012;30:187–195. [PubMed] [Google Scholar]
8. Khazzaka A, Sarkis R. Fundoplication combined with mediogastric plication. Surg Obes Relat Dis. 2013;9:398–403. [PubMed] [Google Scholar]
9. Crookes PF. Surgical treatment of morbid obesity. Annu Rev Med. 2006;57:243–264. [PubMed] [Google Scholar]
10. Power ML, Schulkin J. Anticipatory physiological regulation in feeding biology: cephalic phase responses. Appetite. 2008;50:194–206. [PMC free article] [PubMed] [Google Scholar]
11. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes. 2001;50(8):1714–1719. [PubMed PMID: 11473029]. [PubMed] [Google Scholar]
12. Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes. 2001;50:707–709. [PubMed] [Google Scholar]
13. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med. 2002;346:1623–1630. [PubMed] [Google Scholar]
14. Bose M, Machineni S, Olivan B, Teixeira J, McGinty JJ, Bawa B, et al. Superior appetite hormone profile after equivalent weight loss by gastric bypass compared to gastric banding. Obesity. 2010;18:1085–1091. [PMC free article] [PubMed] [Google Scholar]
15. Karamanakos SN, Vagenas K, Kalfarentzos F, Alexandrides TK. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg. 2008;247:401–407. [PubMed] [Google Scholar]
16. Wang HT, Lu QC, Wang Q, Wang RC, Zhang Y, Chen HL, et al. Role of the duodenum in regulation of plasma ghrelin levels and body mass index after subtotal gastrectomy. World J Gastroenterol. 2008;14:2425–2429. [PMC free article] [PubMed] [Google Scholar]
17. Adami GF, Cordera R, Marinari G, Lamerini G, Andraghetti G, Scopinaro N. Plasma ghrelin concentratin in the short-term following biliopancreatic diversion. Obes Surg. 2003;13:889–892. [PubMed] [Google Scholar]
18. Teff K. Nutritional implications of the cephalic phase reflexes: endocrine responses. Appetite. 2000;34:206–213. [PubMed] [Google Scholar]
19. Kojima S, Ueno N, Asakawa A, Sagiyama K, Naruo T, Mizuno S, et al. A role for pancreatic polypeptide in feeding and body weight regulation. Peptides. 2007;28:459–463. [PubMed] [Google Scholar]
20. Ramon JM, Salvans S, Crous X, Puig S, Goday A, Benaiges D, et al. Effect of Roux-en-Y gastric bypass vs sleeve gastrectomy on glucose and gut hormones: a prospective randomised trial. J Gastrointest Surg. 2012;16:1116–1122. [PubMed] [Google Scholar]
21. Holdstock C, Zethelius B, Sundbom M, Karlsson FA, Eden Engstrom B. Postprandial changes in gut regulatory peptides in gastric bypass patients. Int J Obes. 2008;32:1640–1646. [PubMed] [Google Scholar]
22. Swarbrick MM, Stanhope KL, Austrheim-Smith IT, Van Loan MD, Ali MR, Wolfe BM, et al. Longitudinal changes in pancreatic and adipocyte hormones following Roux-en-Y gastric bypass surgery. Diabetologia. 2008;51:1901–1911. [PMC free article] [PubMed] [Google Scholar]
23. Schrumpf E, Linnestad P, Nygaard K, Giercksky KE, Fausa O. Pancreatic polypeptide secretion before and after gastric bypass surgery for morbid obesity. Scand J Gastroenterol. 1981;16:1009–1014. [PubMed] [Google Scholar]
24. Rehfeld JF. Incretin physiology beyond glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: cholecystokinin and gastrin peptides. Acta Physiol. 2011;201:405–411. [PubMed] [Google Scholar]
25. Lloyd KC. Gut hormones in gastric function. Bailliere’s Clin Endocrinol Metab. 1994;8:111–136. [PubMed] [Google Scholar]
26. Schrumpf E, Giercksky KE, Nygaard K, Fausa O. Gastrin secretion before and after gastric bypass surgery for morbid obesity. Scand J Gastroenterol. 1981;16:721–725. [PubMed] [Google Scholar]
27. Ferzli GS, Dominique E, Ciaglia M, Bluth MH, Gonzalez A, Fingerhut A. Clinical improvement after duodenojejunal bypass for non-obese type 2 diabetes despite minimal improvement in glycemic homeostasis. World J Surg. 2009;33:972–979. [PubMed] [Google Scholar]
28. Jacobsen SH, Olesen SC, Dirksen C, Jorgensen NB, Bojsen-Moller KN, Kielgast U, et al. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in nondiabetic subjects. Obes Surg. 2012;22:1084–1096. [PubMed] [Google Scholar]
29. Stenstrom B, Zhao CM, Tommeras K, Arum CJ, Chen D. Is gastrin partially responsible for body weight reduction after gastric bypass? Eur Surg Res. 2006;38:94–101. [PubMed] [Google Scholar]
30. Godlewski AE, Veyrune JL, Nicolas E, Ciangura CA, Chaussain CC, Czernichow S, et al. Effect of dental status on changes in mastication in patients with obesity following bariatric surgery. PloS One. 2011;6:e22324. [PMC free article] [PubMed] [Google Scholar]
31. Laferrère B. Gut feelings about diabetes. Endocrinol Nutr. 2012;59:254–260. [PMC free article] [PubMed] [Google Scholar]
32. Laurenius A, Larsson I, Bueter M, Melanson KJ, Bosaeus I, Forslund HB, et al. Changes in eating behaviour and meal pattern following Roux-en-Y gastric bypass. Int J Obes. 2012;36:348–355. [PubMed] [Google Scholar]
33. Tichansky DS, Boughter JD, Jr, Madan AK. Taste change after laparoscopic Roux-en-Y gastric bypass and laparoscopic adjustable gastric banding. Surg Obes Relat Dis. 2006;2:440–444. [PubMed] [Google Scholar]
34. Bueter M, Miras AD, Chichger H, Fenske W, Ghatei MA, Bloom SR, et al. Alterations of sucrose preference after Roux-en-Y gastric bypass. Physiol Behav. 2011;104:709–721. [PubMed] [Google Scholar]
35. Ochner CN, Kwok Y, Conceicao E, Pantazatos SP, Puma LM, Carnell S, et al. Selective reduction in neural responses to high calorie foods following gastric bypass surgery. Ann Surg. 2011;253:502–507. [PMC free article] [PubMed] [Google Scholar]
36. Oliveira-Maia AJ, Roberts CD, Simon SA, Nicolelis MA. Gustatory and reward brain circuits in the control of food intake. Adv Tech Stand Neurosurg. 2011;36:31–59. [PMC free article] [PubMed] [Google Scholar]
37. Kokkinos A, le Roux CW, Alexiadou K, Tentolouris N, Vincent RP, Kyriaki D, et al. Eating slowly increases the postprandial response of the anorexigenic gut hormones, peptide YY and glucagon-like peptide-1. J Clin Endocrinol Metab. 2010;95:333–337. [PubMed] [Google Scholar]
38. Horowitz M, Cook DJ, Collins PJ, Harding PE, Hooper MJ, Walsh JF, et al. Measurement of gastric emptying after gastric bypass surgery using radionuclides. Br J Surg. 1982;69:655–657. [PubMed] [Google Scholar]
39. Kotler DP, Sherman D, Bloom SR, Holt PR. Malnutrition after gastric surgery. Association with exaggerated distal intestinal hormone release. Dig Dis Sci. 1985;30:193–199. [PubMed] [Google Scholar]
40. Morinigo R, Moize V, Musri M, Lacy AM, Navarro S, Marin JL, et al. Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab. 2006;91:1735–1740. [PubMed] [Google Scholar]
41. Wang G, Agenor K, Pizot J, Kotler DP, Harel Y, Van Der Schueren BJ, et al. Accelerated gastric emptying but no carbohydrate malabsorption 1 year after gastric bypass surgery (GBP) Obes Surg. 2012;22:1263–1267. [PMC free article] [PubMed] [Google Scholar]
42. Padoin AV, Galvao Neto M, Moretto M, Barancelli F, Schroer CE, Mottin CC. Obese patients with type 2 diabetes submitted to banded gastric bypass: greater incidence of dumping syndrome. Obes Surg. 2009;19:1481–1484. [PubMed] [Google Scholar]
43. Braghetto I, Davanzo C, Korn O, Csendes A, Valladares H, Herrera E, et al. Scintigraphic evaluation of gastric emptying in obese patients submitted to sleeve gastrectomy compared to normal subjects. Obes Surg. 2009;19:1515–1521. [PubMed] [Google Scholar]
44. Melissas J, Daskalakis M, Koukouraki S, Askoxylakis I, Metaxari M, Dimitriadis E, et al. Sleeve gastrectomy-a “food limiting” operation. Obes Surg. 2008;18:1251–1256. [PubMed] [Google Scholar]
45. Bernstine H, Tzioni-Yehoshua R, Groshar D, Beglaibter N, Shikora S, Rosenthal RJ, et al. Gastric emptying is not affected by sleeve gastrectomy – scintigraphic evaluation of gastric emptying after sleeve gastrectomy without removal of the gastric antrum. Obes Surg. 2009;19:293–298. [PubMed] [Google Scholar]
46. McLaughlin T, Peck M, Holst J, Deacon C. Reversible hyperinsulinemic hypoglycemia after gastric bypass: a consequence of altered nutrient delivery. J Clin Endocrinol Metab. 2010;95:1851–1855. [PubMed] [Google Scholar]
47. Holst JJ. On the physiology of GIP and GLP-1. Horm Metab Res. 2004;36:747–754. [PubMed] [Google Scholar]
48. Borg CM, le Roux CW, Ghatei MA, Bloom SR, Patel AG. Biliopancreatic diversion in rats is associated with intestinal hypertrophy and with increased GLP-1, GLP-2 and PYY levels. Obes Surg. 2007;17:1193–1198. [PubMed] [Google Scholar]
49. Tsoli M, Chronaiou A, Kehagias I, Kalfarentzos F, Alexandrides TK. Hormone changes and diabetes resolution after biliopancreatic diversion and laparoscopic sleeve gastrectomy: a comparative prospective study. Surg Obes Relat Dis. 2013;9:667–677. [PubMed] [Google Scholar]
50. Bose M, Teixeira J, Olivan B, Bawa B, Arias S, Machineni S, et al. Weight loss and incretin responsiveness improve glucose control independently after gastric bypass surgery. J Diabetes. 2010;2:47–55. [PMC free article] [PubMed] [Google Scholar]
51. Rao RS, Kini S. GIP and bariatric surgery. Obes Surg. 2011;21:244–252. [PubMed] [Google Scholar]
52. De Silva A, Bloom SR. Gut hormones and appetite control: a focus on PYY and GLP-1 as therapeutic targets in obesity. Gut Liver. 2012;6:10–20. [PMC free article] [PubMed] [Google Scholar]
53. Boggiano MM, Chandler PC, Oswald KD, Rodgers RJ, Blundell JE, Ishii Y, et al. PYY3-36 as an anti-obesity drug target. Obes Rev. 2005;6:307–322. [PubMed] [Google Scholar]
54. Olivan B, Teixeira J, Bose M, Bawa B, Chang T, Summe H, et al. Effect of weight loss by diet or gastric bypass surgery on peptide YY3-36 levels. Ann Surg. 2009;249:948–953. [PMC free article] [PubMed] [Google Scholar]
55. Vincent RP, le Roux CW. Changes in gut hormones after bariatric surgery. Clin Endocrinol. 2008;69:173–179. [PubMed] [Google Scholar]
56. Cohen MA, Ellis SM, Le Roux CW, Batterham RL, Park A, Patterson M, et al. Oxyntomodulin suppresses appetite and reduces food intake in humans. J Clin Endocrinol Metab. 2003;88:4696–4701. [PubMed] [Google Scholar]
57. Schjoldager B, Mortensen PE, Myhre J, Christiansen J, Holst JJ. Oxyntomodulin from distal gut. Role in regulation of gastric and pancreatic functions. Dig Dis Sci. 1989;34:1411–1419. [PubMed] [Google Scholar]
58. Laferrère B, Swerdlow N, Bawa B, Arias S, Bose M, Olivan B, et al. Rise of oxyntomodulin in response to oral glucose after gastric bypass surgery in patients with type 2 diabetes. J Clin Endocrinol Metab. 2010;95:4072–4076. [PMC free article] [PubMed] [Google Scholar]
59. Neary MT, Batterham RL. Gut hormones: implications for the treatment of obesity. Pharmacol Ther. 2009;124:44–56. [PubMed] [Google Scholar]
60. Foschi D, Corsi F, Pisoni L, Vago T, Bevilacqua M, Asti E, et al. Plasma cholecystokinin levels after vertical banded gastroplasty: effects of an acidified meal. Obes Surg. 2004;14:644–647. [PubMed] [Google Scholar]
61. Naslund E, Gryback P, Hellstrom PM, Jacobsson H, Holst JJ, Theodorsson E, et al. Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity. Int J Obes Relat Metab Disord. 1997;21:387–392. [PubMed] [Google Scholar]
62. Peterli R, Steinert RE, Woelnerhanssen B, Peters T, Christoffel-Courtin C, Gass M, et al. Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial. Obes Surg. 2012;22:740–748. [PMC free article] [PubMed] [Google Scholar]
63. Koch TR, Finelli FC. Postoperative metabolic and nutritional complications of bariatric surgery. Gastroenterol Clin N Am. 2010;39:109–124. [PubMed] [Google Scholar]
64. Shankar P, Boylan M, Sriram K. Micronutrient deficiencies after bariatric surgery. Nutrition. 2010;26:1031–1037. [PubMed] [Google Scholar]
65. Odstrcil EA, Martinez JG, Santa Ana CA, Xue B, Schneider RE, Steffer KJ, et al. The contribution of malabsorption to the reduction in net energy absorption after long-limb Roux-en-Y gastric bypass. Am J Clin Nutr. 2010;92:704–713. [PubMed] [Google Scholar]
66. Kumar R, Lieske JC, Collazo-Clavell ML, Sarr MG, Olson ER, Vrtiska TJ, et al. Fat malabsorption and increased intestinal oxalate absorption are common after Roux-en-Y gastric bypass surgery. Surgery. 2011;149:654–661. [PMC free article] [PubMed] [Google Scholar]
67. Stemmer K, Bielohuby M, Grayson BE, Begg DP, Chambers AP, Neff C, et al. Roux-en-Y gastric bypass surgery but not vertical sleeve gastrectomy decreases bone mass in male rats. Endocrinology. 2013;154:2015–2024. [PMC free article] [PubMed] [Google Scholar]
68. Maljaars PW, Peters HP, Mela DJ, Masclee AA. Ileal brake: a sensible food target for appetite control. A review. Physiol Behav. 2008;95:271–281. [PubMed] [Google Scholar]
69. Strader AD, Vahl TP, Jandacek RJ, Woods SC, D’Alessio DA, Seeley RJ. Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats. Am J Physiol Endocrinol Metab. 2005;288:E447–E453. [PubMed] [Google Scholar]
70. Cummings BP, Strader AD, Stanhope KL, Graham JL, Lee J, Raybould HE, et al. Ileal interposition surgery improves glucose and lipid metabolism and delays diabetes onset in the UCD-T2DM rat. Gastroenterology. 2010;138:2437–2446. [46 e1]. [PMC free article] [PubMed] [Google Scholar]
71. Patriti A, Facchiano E, Annetti C, Aisa MC, Galli F, Fanelli C, et al. Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model. Obes Surg. 2005;15:1258–1264. [PubMed] [Google Scholar]
72. Mithieux G. A novel function of intestinal gluconeogenesis: central signaling in glucose and energy homeostasis. Nutrition. 2009;25:881–884. [PubMed] [Google Scholar]
73. Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg. 2004;239:1–11. [PMC free article] [PubMed] [Google Scholar]
74. Saeidi N, Meoli L, Nestoridi E, Gupta NK, Kvas S, Kucharczyk J, et al. Reprogramming of intestinal glucose metabolism and glycemic control in rats after gastric bypass. Science. 2013;341:406–410. [PMC free article] [PubMed] [Google Scholar]
75. Pories WJ, Mehaffey JH, Staton KM. The surgical treatment of type two diabetes mellitus. Surg Clin N Am. 2011;91:821–836. [viii]. [PubMed] [Google Scholar]
76. Chambers AP, Jessen L, Ryan KK, Sisley S, Wilson-Perez HE, Stefater MA, et al. Weight-independent changes in blood glucose homeostasis after gastric bypass or vertical sleeve gastrectomy in rats. Gastroenterology. 2011;141:950–958. [PMC free article] [PubMed] [Google Scholar]
77. Promintzer-Schifferl M, Prager G, Anderwald C, Mandl M, Esterbauer H, Shakeri-Leidenmuhler S, et al. Effects of gastric bypass surgery on insulin resistance and insulin secretion in nondiabetic obese patients. Obesity. 2011;19:1420–1426. [PubMed] [Google Scholar]
78. Dunn JP, Abumrad NN, Breitman I, Marks-Shulman PA, Flynn CR, Jabbour K, et al. Hepatic and peripheral insulin sensitivity and diabetes remission at 1 month after Roux-en-Y gastric bypass surgery in patients randomized to omentectomy. Diabetes Care. 2012;35:137–142. [PMC free article] [PubMed] [Google Scholar]
79. Klein S, Mittendorfer B, Eagon JC, Patterson B, Grant L, Feirt N, et al. Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease. Gastroenterology. 2006;130:1564–1572. [PubMed] [Google Scholar]
80. Kral JG, Thung SN, Biron S, Hould FS, Lebel S, Marceau S, et al. Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis. Surgery. 2004;135:48–58. [PubMed] [Google Scholar]
81. Patti ME, Houten SM, Bianco AC, Bernier R, Larsen PR, Holst JJ, et al. Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. Obesity. 2009;17:1671–1677. [PMC free article] [PubMed] [Google Scholar]
82. Houten SM, Watanabe M, Auwerx J. Endocrine functions of bile acids. EMBO J. 2006;25:1419–1425. [PubMed PMID: 16541101]. [PMC free article] [PubMed] [Google Scholar]
83. Simonen M, Dali-Youcef N, Kaminska D, Venesmaa S, Kakela P, Paakkonen M, et al. Conjugated bile acids associate with altered rates of glucose and lipid oxidation after Roux-en-Y gastric bypass. Obes Surg. 2012;22(9):1473–1480. [PubMed PMID: 22638681]. [PMC free article] [PubMed] [Google Scholar]
84. Ahmad NN, Pfalzer A, Kaplan LM. Roux-en-Y gastric bypass normalizes the blunted postprandial bile acid excursion associated with obesity. Int J Obes. 2013 [doi:10.1038]. [PMC free article] [PubMed] [Google Scholar]
85. Pournaras DJ, Glicksman C, Vincent RP, Kuganolipava S, Alaghband-Zadeh J, Mahon D, et al. The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. Endocrinology. 2012;153:3613–3619. [PMC free article] [PubMed] [Google Scholar]
86. Bruusgaard A, Sorensen TI, Justesen T, Krag E. Bile acid metabolism after jejunoileal bypass operation for obesity. Scand J Gastroenterol. 1976;11:833–838. [PubMed] [Google Scholar]
87. Fromm H, Sarva RP, Ravitch MM, McJunkin B, Farivar S, Amin P. Effects of jejunoileal bypass on the enterohepatic circulation of bile acids, bacterial flora in the upper small intestine, and absorption of vitamin B12. Metab Clin Exp. 1983;32:1133–1141. [PubMed] [Google Scholar]
88. Watanabe M, Houten SM, Mataki C, Christoffolete MA, Kim BW, Sato H, et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature. 2006;439:484–489. [PubMed] [Google Scholar]
89. Bharucha AE. Lower gastrointestinal functions. Neurogastroenterol Motil. 2008;20(Suppl. 1):103–113. [PubMed] [Google Scholar]
90. Nordgaard I, Hansen BS, Mortensen PB. Importance of colonic support for energy absorption as small bowel failure proceeds. Am J Clin Nutr. 1996;64:222–231. [PubMed] [Google Scholar]
91. Salminen S, Bouley C, Boutron-Ruault MC, Cummings JH, Franck A, Gibson GR, et al. Functional food science and gastrointestinal physiology and function. Br J Nutr. 1998;80(Suppl 1):S147–S171. [PubMed] [Google Scholar]
92. Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A. 2005;102:11070–11075. [PMC free article] [PubMed] [Google Scholar]
93. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature. 2006;444:1022–1023. [PubMed] [Google Scholar]
94. Larsen N, Vogensen FK, van den Berg FW, Nielsen DS, Andreasen AS, Pedersen BK, et al. Gut microbiota in human adults with type 2 diabetes differs from nondiabetic adults. PloS One. 2010;5:e9085. [PMC free article] [PubMed] [Google Scholar]
95. Zhang H, DiBaise JK, Zuccolo A, Kudrna D, Braidotti M, Yu Y, et al. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A. 2009;106:2365–2370. [PMC free article] [PubMed] [Google Scholar]
96. Furet JP, Kong LC, Tap J, Poitou C, Basdevant A, Bouillot JL, et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes. 2010;59:3049–3057. [PMC free article] [PubMed] [Google Scholar]
97. Woodard GA, Encarnacion B, Downey JR, Peraza J, Chong K, Hernandez-Boussard T, et al. Probiotics improve outcomes after Roux-en-Y gastric bypass surgery: a prospective randomized trial. J Gastrointest Surg. 2009;13:1198–1204. [PubMed] [Google Scholar]
98. Olubuyide IO, Williamson RC, Bristol JB, Read AE. Goblet cell hyperplasia is a feature of the adaptive response to jejunoileal bypass in rats. Gut. 1984;25:62–68. [PMC free article] [PubMed] [Google Scholar]
99. le Roux CW, Borg C, Wallis K, Vincent RP, Bueter M, Goodlad R, et al. Gut hypertrophy after gastric bypass is associated with increased glucagon-like peptide 2 and intestinal crypt cell proliferation. Ann Surg. 2010;252:50–56. [PubMed] [Google Scholar]
100. le Roux CW, Aylwin SJ, Batterham RL, Borg CM, Coyle F, Prasad V, et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg. 2006;243:108–114. [PMC free article] [PubMed] [Google Scholar]
101. Pories W. Diagram of surgical options. 2009 [Online]. Online; [cited 2013]. Available from: http://win.niddk.nih.gov/publications/gastric.htm.
